Tetracyclines enhance antitumor T-cell immunity via the Zap70 signaling pathway by Atsushi Kumanogoh, Hisashi Wada, Yoshito Takeda, Mari Tone, Yasushi Shintani, Kota Iwahori, Michinari Hirata, Azumi Ueyama, Akiyoshi Tani, Jun-Ichi Haruta

Get full text

48 Blood-based peripheral T cell cytotoxicity assay in predicting response to immune checkpoint inhibitors: a US pilot study by Yali Li, Rajesh Nair, Shumei Kato, Suzanna Lee, Kota Iwahori, Jonathon Woo, Michele Baltay, Junichi Akatsuka, Srinath Sampath, Christian Schmedt, Srihari Sampath

In situ analysis of CCR8+ regulatory T cells in lung cancer: suppression of GzmB+ CD8+ T cells and prognostic marker implications by Yoshinori Hayashi, Azumi Ueyama, Soichiro Funaki, Koichi Jinushi, Naoko Higuchi, Hitomi Morihara, Michinari Hirata, Yoji Nagira, Takuro Saito, Atsunari Kawashima, Kota Iwahori, Yasushi Shintani, Hisashi Wada

Get full text

Impact of minocycline on outcomes of EGFR-mutant non-small cell lung cancer patients treated with EGFR-TKIs by Mari Tone, Kota Iwahori, Takayuki Shiroyama, Shinji Futami, Yujiro Naito, Kiyoharu Fukushima, Kotaro Miyake, Shohei Koyama, Haruhiko Hirata, Izumi Nagatomo, Hisashi Wada, Yoshito Takeda, Atsushi Kumanogoh

Get full text

Enhancing the efficacy of near-infrared photoimmunotherapy through intratumoural delivery of CD44–targeting antibody–photoabsorber conjugatesResearch in context by Yuichi Adachi, Kotaro Miyake, Kika Ohira, Shingo Satoh, Kentaro Masuhiro, Ryuya Edahiro, Yuya Shirai, Maiko Naito, Yujiro Naito, Takayuki Shiroyama, Shohei Koyama, Haruhiko Hirata, Kota Iwahori, Izumi Nagatomo, Yoshito Takeda, Atsushi Kumanogoh

Get full text

A randomized phase 2 study on demeclocycline in patients with mild-to-moderate COVID-19 by Kota Iwahori, Takuro Nii, Norihiko Yamaguchi, Takahiro Kawasaki, Satomi Okamura, Kazuki Hashimoto, Takanori Matsuki, Kazuyuki Tsujino, Keisuke Miki, Akio Osa, Sho Goya, Kinya Abe, Masahide Mori, Yoshito Takeda, Tomomi Yamada, Hiroshi Kida, Atsushi Kumanogoh

Get full text

Peripheral T cell cytotoxicity predicts the efficacy of anti-PD-1 therapy for advanced non-small cell lung cancer patients by Kota Iwahori, Takeshi Uenami, Yukihiro Yano, Toshihiko Ueda, Mari Tone, Yujiro Naito, Yasuhiko Suga, Kiyoharu Fukushima, Takayuki Shiroyama, Kotaro Miyake, Shohei Koyama, Haruhiko Hirata, Izumi Nagatomo, Hiroshi Kida, Masahide Mori, Yoshito Takeda, Atsushi Kumanogoh, Hisashi Wada

Get full text

Real-world impact of antifibrotics on prognosis in patients with progressive fibrosing interstitial lung disease by Atsushi Kumanogoh, Sho Komukai, Takuro Nii, Shinichi Iwakoshi, Hiroshi Kida, Yoshito Takeda, Kota Iwahori, Takayuki Shiroyama, Masahiro Yanagawa, Keisuke Miki, Takayuki Niitsu, Kiyoharu Fukushima, So Takata, Yuko Abe, Tomoki Kuge, Kotaro Miyake, Kazuyuki Tujino, Satoshi Tanizaki, Haruhiko Hirata, Noriyuki Takeuchi

Get full text

Potential asthma biomarkers identified by nontargeted proteomics of extracellular vesicles in exhaled breath condensate by Reina Hara, MD, Yoshito Takeda, MD, PhD, Takatoshi Enomoto, MD, Hanako Yoshimura, MD, PhD, Makoto Yamamoto, MD, Satoshi Tanizaki, MD, Yuya Shirai, MD, PhD, Takahiro Kawasaki, MD, PhD, Mana Nakayama, Saori Amiya, MD, Yuichi Adachi, MD, Yoshimi Noda, MD, Takayuki Niitsu, MD, Ryuya Edahiro, MD, PhD, Moto Yaga, MD, PhD, Yuki Hosono, MD, PhD, Maiko Naito, MD, PhD, Kentaro Masuhiro, MD, PhD, Yujiro Naito, MD, PhD, Takayuki Shiroyama, MD, PhD, Kotaro Miyake, MD, PhD, Kiyoharu Fukushima, MD, PhD, Shohei Koyama, MD, PhD, Kota Iwahori, MD, PhD, Haruhiko Hirata, MD, Izumi Nagatomo, MD, PhD, Yusuke Kawashima, PhD, Mari Nogami-Itoh, PhD, Atsushi Kumanogoh, MD, PhD

Get full text